Combined Therapy of Stent‐Grafts With Other Scaffolds in Femoro‐Popliteal Artery
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.70093 ↗At a glance
Multizentrische Studie in Catheterization and Cardiovascular Interventions, 2025. Written by Yo Iwata and 8 co-authors. Institution: Department of Cardiology, Funabashi Municipal Medical Center, Chiba, Japan. Major MEDLINE topics: Popliteal Artery, Femoral Artery, Peripheral Arterial Disease, Stents. 17 references. Funded by: The authors received no specific funding for this work..
Abstract (original language)
Background
With endovascular treatment (EVT) becoming the preferred approach for long femoro‐popliteal (FP) lesions, stent‐grafts (SGs) have seen increased use in practice.
Aims
This study assessed the efficacy of combining SGs with other scaffold devices in treating long FP lesions in patients with symptomatic lower extremity arterial disease.
Methods
This study retrospectively reviewed 3132 patients treated with EVT for FP lesions at seven cardiovascular centers in eastern Japan between January 2017 and February 2021. Acute limb ischemia treatments were excluded from this analysis. We performed propensity score matching to compare patency rates between cases treated with SGs combined with other scaffold devices and those treated with SGs alone.
Results
This study enrolled 291 participants. We assigned 81 cases to the combined‐use group and 210 to the SG‐alone group. Propensity score matching yielded 41 matched pairs exhibiting no significant differences in baseline characteristics, including lesion length (28.4 ± 10.3 vs. 27.7 ± 9.3 cm). The 1‐year rate of freedom from restenosis was 71.6% in the combined‐use group compared with 84.6% in the SG‐alone group; the corresponding 3‐year rate was 64.4% versus 72.6% ( p = 0.83). No statistically significant differences were observed between the two groups in terms of freedom from target lesion revascularization, occlusive restenosis, or acute limb ischemia ( p = 0.99, 0.72, and 0.11, respectively).
Conclusion
Both treatment strategies yielded acceptable outcomes in the management of complex FP lesions. Although the combined‐use group experienced an earlier decline in patency than the SG‐alone group, this difference was not statistically significant. Trial Registration Since this study is a retrospective analysis from a multicenter registry, trial registration is unnecessary.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Cardiology, Funabashi Municipal Medical Center, Chiba, Japan.
- Department of Laboratory Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
- Department of Cardiology, Shonan Kamakura General Hospital, Kamakura, Japan.
- Department of Cardiovascular Medicine, Asahi General Hospital, Chiba, Japan.
- Department of Cardiology, Yokohama-City Tobu Hospital, Yokohama, Japan.
- Department of Cardiology, Sendai Kousei Hospital, Sendai, Japan.
ORCID profiles: Yo Iwata, Mitsuyoshi Takahara, Kazuki Tobita, Naoki Hayakawa, Shinsuke Mori, Kazunori Horie, Tatsuya Nakama, Kenji Suzuki, Shigeru Fukuzawa
Funding
- The authors received no specific funding for this work.
Cite
APA
Iwata, Y., Takahara, M., Tobita, K., Hayakawa, N., Mori, S., Horie, K., Nakama, T., Suzuki, K., & Fukuzawa, S. (2025). Combined Therapy of Stent‐Grafts With Other Scaffolds in Femoro‐Popliteal Artery. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70093
Vancouver
Iwata Y, Takahara M, Tobita K, Hayakawa N, Mori S, Horie K, et al. Combined Therapy of Stent‐Grafts With Other Scaffolds in Femoro‐Popliteal Artery. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70093
BibTeX
@article{Iwata2025,
author = {Iwata, Yo and Takahara, Mitsuyoshi and Tobita, Kazuki and Hayakawa, Naoki and Mori, Shinsuke and Horie, Kazunori and Nakama, Tatsuya and Suzuki, Kenji and Fukuzawa, Shigeru},
title = {Combined Therapy of Stent‐Grafts With Other Scaffolds in Femoro‐Popliteal Artery},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.70093}
}
EUVIMED